A carregar...

Does venous thromboembolism prophylaxis affect the risk of venous thromboembolism and adverse events following primary hip and knee replacement? A retrospective cohort study

BACKGROUND: The optimum chemical venous thromboembolism (VTE) prophylactic agents following total hip and knee replacement (THR and TKR) remain unknown. NICE recommends multiple agents, including direct oral anticoagulants (DOACs), low-molecular weight heparin (LMWH), and aspirin. We assessed whethe...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Orthop
Main Authors: Todd, F., Yeomans, D., Whitehouse, M.R., Matharu, G.S.
Formato: Artigo
Idioma:Inglês
Publicado em: Elsevier 2021
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8181578/
https://ncbi.nlm.nih.gov/pubmed/34140759
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jor.2021.05.030
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!